BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH
196 results:

  • 1. Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor.
    Wangsiricharoen S; Ingram DR; Morey RR; Wani K; Lazar AJ; Wang WL
    Mod Pathol; 2024 Mar; 37(3):100426. PubMed ID: 38219952
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association of Geriatric Nutritional Risk Index With Immune Checkpoint Inhibitor Treatment Duration and Adverse Events in Lung cancer.
    Shimizu A; Fukasawa M; Mitani K; Goto K; Wakamoto A; Hatsuyama T; Hoshi T; Hasegawa I; Sato H
    In Vivo; 2024; 38(1):418-424. PubMed ID: 38148096
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Single Nucleotide Polymorphisms in DNA Repair Genes (XRCC1, XRCC2, XRCC3) and Their Association with Radiotherapy Toxicity among Head and Neck cancer Patients:A Study from South-Western Maharashtra.
    Gudur AK; Gudur RA; Bhosale SJ; Kale SR; Datkhile KD
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3049-3057. PubMed ID: 37774056
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathological features and differential diagnosis of gastric metastases.
    Chen W; Liu C; Liu Y; Yuan J; Wang Z
    World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Lung cancer with breast metastasis: a case report and review of the literature.
    Cao X; Chen P; Agyekum EA; Zhang Q; Qian X; Wu T; Chambers KH; Yin L
    J Int Med Res; 2023 Jul; 51(7):3000605231188287. PubMed ID: 37523488
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Case report: Metastasis of Merkel cell carcinoma in the small intestine.
    Chyzhma R; Piddubnyi A; Romaniuk A; Moskalenko R
    Pathol Res Pract; 2023 Aug; 248():154594. PubMed ID: 37301085
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Interaction between Age and Primary Site on Survival Outcomes in Primary GI Melanoma over the Past Decade.
    Bangolo A; Fwelo P; Sagireddy S; Shah H; Trivedi C; Bukasa-Kakamba J; Patel R; Bharane L; Randhawa MK; Nagesh VK; Dey S; Terefe H; Kaur G; Dinko N; Emiroglu FL; Mohamed A; Fallorina MA; Kosoy D; Waqar D; Shenoy A; Ahmed K; Nanavati A; Singh A; Willie A; Gonzalez DMC; Mukherjee D; Sajja J; Proverbs-Singh T; Elias S; Weissman S
    Med Sci (Basel); 2023 Apr; 11(2):. PubMed ID: 37218984
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Patterns of Immunoreactivity with ttf-1 Antibodies 8G7G3/1 and SPT24 Suggest Distinct Immunoprofiles Between Most Pulmonary and Nonpulmonary Small Cell Carcinomas.
    Briski LM; Aron M; Epstein JI; Russell DH; Assarzadegan N; Delma KS; O'Dell H; Rodriguez E; Montgomery EA; Kryvenko ON
    Int J Surg Pathol; 2024 Apr; 32(2):230-238. PubMed ID: 37170625
    [No Abstract]    [Full Text] [Related]  

  • 9. Real-world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy.
    Lee S; Bennett AV; Zhou X; Betof Warner A; Trogdon JG; Kent EE; Lund JL
    Pharmacoepidemiol Drug Saf; 2023 Sep; 32(9):988-1000. PubMed ID: 37095605
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. skin-sparing mastectomy for the treatment of breast cancer.
    Mota BS; Bevilacqua JLB; Barrett J; Ricci MD; Munhoz AM; Filassi JR; Baracat EC; Riera R
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010993. PubMed ID: 36972145
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.
    Lev-Ari S; Serzan M; Wu T; Ip A; Pascual L; Sinclaire B; Adams S; Marafelias M; Ayyagari L; Gill SK; Ma B; Zaemes JP; Della Pia A; Alaoui A; Madhavan S; Belouali A; Pecora A; Ahn J; Atkins MB; Shah NJ
    Cancer; 2023 Jun; 129(12):1885-1894. PubMed ID: 36951119
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Safety and efficacy of tumour-treating fields (ttfields) therapy for newly diagnosed glioblastoma in Japanese patients using the Novo-ttf System: a prospective post-approval study.
    Nishikawa R; Yamasaki F; Arakawa Y; Muragaki Y; Narita Y; Tanaka S; Yamaguchi S; Mukasa A; Kanamori M
    Jpn J Clin Oncol; 2023 Apr; 53(5):371-377. PubMed ID: 36647599
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cutaneous metastases of non-cutaneous neuroendocrine neoplasms: A histopathologic review of 15 cases.
    Hobbs MM; Snow JT; Shachner TR; Sokumbi O
    J Cutan Pathol; 2022 Nov; 49(11):960-970. PubMed ID: 36222210
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CK20/CK7 double-negative Merkel cell carcinoma in situ: A case report.
    Richardson WM; Hohmann A; Usmani H; Lozeau D; Huston TL
    J Cutan Pathol; 2022 Nov; 49(11):947-956. PubMed ID: 35748574
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022.
    Gauci ML; Aristei C; Becker JC; Blom A; Bataille V; Dreno B; Del Marmol V; Forsea AM; Fargnoli MC; Grob JJ; Gomes F; Hauschild A; Hoeller C; Harwood C; Kelleners-Smeets N; Kaufmann R; Lallas A; Malvehy J; Moreno-Ramirez D; Peris K; Pellacani G; Saiag P; Stratigos AJ; Vieira R; Zalaudek I; van Akkooi ACJ; Lorigan P; Garbe C; Lebbé C;
    Eur J Cancer; 2022 Aug; 171():203-231. PubMed ID: 35732101
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Does Residual Invasive Disease in Wide Local Excision after Diagnosis with Partial Biopsy Technique Influence Survival in Melanoma? Matched-Pair Analysis of Multicenter Selective Lymphadenectomy Trial I and II.
    Ramiscal JAB; Stern SL; Wilson AK; Lorimer PD; Lee NA; Goldfarb MR; Foshag LJ; Fischer TD
    J Am Coll Surg; 2022 Jul; 235(1):49-59. PubMed ID: 35703962
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Primary cutaneous phalangeal neuroendocrine/squamous cell carcinoma with mixed axillary metastasis.
    McIntyre TV; Connelly TM; O'Hare K; Gillis A
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35351767
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Establishing a Prognostic Model Based on Ulceration and Immune Related Genes in Melanoma Patients and Identification of EIF3B as a Therapeutic Target.
    Wu Z; Lei K; Xu S; He J; Shi E
    Front Immunol; 2022; 13():824946. PubMed ID: 35273605
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Efficacy and Safety Comparison of Regorafenib and Fruquintinib in Metastatic Colorectal cancer-An Observational Cohort Study in the Real World.
    Zhang Q; Chen M; Wang Z; Qi C; Cao Y; Zhang J; Peng Z; Wang X; Lu M; Shen L; Li J
    Clin Colorectal Cancer; 2022 Sep; 21(3):e152-e161. PubMed ID: 35216918
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tumour treating fields in glioblastoma: is the treatment tolerable, effective, and practical in UK patients?
    Olubajo F; Thorpe A; Davis C; Sinha R; Crofton A; Mills SJ; Williams M; Jenkinson MD; Price SJ; Watts C; Brodbelt AR
    Br J Neurosurg; 2022 Dec; 36(6):770-776. PubMed ID: 35200077
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 10.